Hexarelin

Overview

Hexarelin is one of the most potent growth hormone releasing peptides, producing strong GH pulses through ghrelin-receptor activation. It also has cardioprotective properties and may support heart health independent of its GH release. Like most peptides, it is a research chemical needing reconstitution and subcutaneous injection, so purity and storage matter.

Editorial verdict

Hexarelin is a powerful GH secretagogue with a respectable evidence base, but its potency is also its weakness: receptors desensitize fast, so continuous use loses effect, and it tends to push cortisol and prolactin higher than gentler GHRPs. The cardioprotective findings are intriguing but come almost entirely from animal and in vitro work, not human outcome trials. It is a real tool for those who cycle it properly, not a set-and-forget option.

Evidence quality

We rate the research A+, weighted across 94 peer-reviewed studies (34 RCT, 2 observational, 36 animal, 15 in vitro, 7 reviews). Of 94 classified findings, 68 supported, 17 were mixed, and 9 null. The human evidence base includes 34 RCTs, which is strong for a peptide.

What research shows

In humans, Hexarelin reliably stimulated GH secretion across intravenous, subcutaneous, intranasal, and oral routes. The cardiovascular and protective findings are mostly preclinical: in ApoE-knockout mice it slowed atherosclerosis by modulating lipids and suppressing macrophage uptake of oxidized LDL via the LOX-1-NF-κB pathway. A review describes cardioprotection through growth hormone secretagogue receptor binding. In Neuro-2A cells it was neuroprotective, blocking hydrogen-peroxide-induced apoptosis by acting on MAPK and PI3K/Akt pathways. In isolated rat hearts it protected against calcium-paradox damage by restoring electrolyte balance, and in nonobese insulin-resistant MKR mice it corrected glucose intolerance, lowered triglycerides, and normalized body composition.

Who should be cautious

Anyone sensitive to elevated cortisol or prolactin, or prone to bloating and water retention, should be careful. Because tolerance develops rapidly, continuous dosing is counterproductive.

Community sentiment

Community data is thin: across 6 reports, sentiment ran 50% positive and 50% neutral. One report cited strong results; one cited more side effects than expected.

Dosage

A typical range is 100-200 mcg per injection, 2-3 times daily, run in short cycles of about 4-8 weeks on followed by an equal time off, given by subcutaneous injection.

Effectiveness and availability

Hexarelin is highly potent but prone to desensitization, with receptors downregulating during continued use, so short cycles with breaks are needed to keep it working. It is available from peptide suppliers but is less commonly stocked than GHRP-2 or GHRP-6, making reputable sourcing especially important.